Literature DB >> 9660832

Translation eukaryotic initiation factor 4G recognizes a specific structural element within the internal ribosome entry site of encephalomyocarditis virus RNA.

V G Kolupaeva1, T V Pestova, C U Hellen, I N Shatsky.   

Abstract

A complex of eukaryotic initiation factors (eIFs) 4A, 4E, and 4G (collectively termed eIF4F) plays a key role in recruiting mRNAs to ribosomes during translation initiation. The site of ribosomal entry onto most mRNAs is determined by interaction of the 5'-terminal cap with eIF4E; eIFs 4A and 4G may facilitate ribosomal entry by modifying mRNA structure near the cap and by interacting with ribosome-associated factors. eIF4G recruits uncapped encephalomyocarditis virus (EMCV) mRNA to ribosomes without the involvement of eIF4E by binding directly to the approximately 450-nucleotide long EMCV internal ribosome entry site (IRES). We have used chemical and enzymatic probing to map the eIF4G binding site to a structural element within the J-K domain of the EMCV IRES that consists of an oligo(A) loop at the junction of three helices. The oligo(A) loop itself is not sufficient to form stable complexes with eIF4G since alteration of its structural context abolished its interaction with eIF4G. Addition of wild type or trans-dominant mutant forms of eIF4A to binary IRES.eIF4G complexes did not further alter the pattern of chemical/enzymatic modification of the IRES.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660832     DOI: 10.1074/jbc.273.29.18599

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Differentiation-induced internal translation of c-sis mRNA: analysis of the cis elements and their differentiation-linked binding to the hnRNP C protein.

Authors:  O Sella; G Gerlitz; S Y Le; O Elroy-Stein
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Functionality of the STNV translational enhancer domain correlates with affinity for two wheat germ factors.

Authors:  R van Lipzig; M Van Montagu; M Cornelissen; F Meulewaeter
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

3.  Structure and function of a cap-independent translation element that functions in either the 3' or the 5' untranslated region.

Authors:  L Guo; E Allen; W A Miller
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

4.  Cytoplasmic polyadenylation elements mediate masking and unmasking of cyclin B1 mRNA.

Authors:  C H de Moor; J D Richter
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

5.  Cap-independent translation conferred by the 5' leader of tobacco etch virus is eukaryotic initiation factor 4G dependent.

Authors:  D R Gallie
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Truncated initiation factor eIF4G lacking an eIF4E binding site can support capped mRNA translation.

Authors:  I K Ali; L McKendrick; S J Morley; R J Jackson
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

7.  Computational modeling of eukaryotic mRNA turnover.

Authors:  D Cao; R Parker
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

8.  The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure.

Authors:  Y V Svitkin; A Pause; A Haghighat; S Pyronnet; G Witherell; G J Belsham; N Sonenberg
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

9.  A cell cycle-dependent protein serves as a template-specific translation initiation factor.

Authors:  E V Pilipenko; T V Pestova; V G Kolupaeva; E V Khitrina; A N Poperechnaya; V I Agol; C U Hellen
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

10.  Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning.

Authors:  Déborah Prévôt; Didier Décimo; Cécile H Herbreteau; Florence Roux; Jérôme Garin; Jean-Luc Darlix; Théophile Ohlmann
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.